COVID-19 Symptom Attestation

Lummi Nation to participate in Phase 3 trial of AstraZeneca’s COVID-19 vaccine

The Bellingham Herald

The Lummi Tribal Health Center will participate in a Phase 3 clinical trial to help determine the efficiency of a COVID-19 vaccine developed by AstraZeneca.

The Lummi Indian Business Council announced that it had unanimously approved participation in the trial for AZD1222 in a release posted to Facebook Wednesday morning, Sept. 16.

“The Lummi Nation has been a public health leader in our proactive response to the COVID-19 pandemic,” Lummi Indian Business Council Chairman Lawrence Solomon said in the release.

Click the heart to favorite

Your feedback is crucial to telling Western's story.
Wednesday, September 16, 2020 - 1:50pm

Share